Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.

Taylor NJ, Mitra N, Qian L, Avril MF, Bishop DT, Paillerets BB, Bruno W, Calista D, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Gruis NA, Hansson J, Harland M, Hayward NK, Hocevar M, Höiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Mann GJ, Nagore E, Olsson H, Palmer JM, Perić B, Pjanova D, Pritchard AL, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KAW, Yang XR, Newton-Bishop JA, Kanetsky PA; GenoMEL Study Group.

J Am Acad Dermatol. 2019 Feb 4. pii: S0190-9622(19)30190-2. doi: 10.1016/j.jaad.2019.01.079. [Epub ahead of print]

PMID:
30731170
2.

Sun protection behaviour and skin cancer literacy among outdoor runners.

Duarte AF, Nagore E, Silva JNM, Picoto A, Pereira AC, Correia OJC.

Eur J Dermatol. 2018 Dec 1;28(6):803-808. doi: 10.1684/ejd.2018.3450.

PMID:
30698149
3.

Multiple facial plaque variant of trichoblastoma.

Requena C, Requena L, Kazakov DV, Traves V, Nagore E, Llombart B, Serra C, Guillén C, Sanmartín O.

J Cutan Pathol. 2019 Jan 10. doi: 10.1111/cup.13416. [Epub ahead of print]

PMID:
30632185
4.

Correction: Cutaneous melanoma primary site is linked to nevus density.

Martin-Gorgojo A, Llinares M, Virós A, Requena C, Garcia-Casado Z, Traves V, Kumar R, Nagore E.

Oncotarget. 2018 Dec 4;9(95):36816. doi: 10.18632/oncotarget.26445. eCollection 2018 Dec 4.

5.

Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.

Kim J, Luo W, Wang M, Wegman-Ostrosky T, Frone MN, Johnston JJ, Nickerson ML, Rotunno M, Li SA, Achatz MI, Brodie SA, Dean M, de Andrade KC, Fortes FP, Gianferante M, Khincha P, McMaster ML, McReynolds LJ, Pemov A, Pinheiro M, Santiago KM, Alter BP, Caporaso NE, Gadalla SM, Goldin LR, Greene MH, Loud J, Yang XR, Freedman ND, Gapstur SM, Gaudet MM, Calista D, Ghiorzo P, Fargnoli MC, Nagore E, Peris K, Puig S, Landi MT, Hicks B, Zhu B, Liu J, Sampson JN, Chanock SJ, Mirabello LJ, Morton LM, Biesecker LG, Tucker MA, Savage SA, Goldstein AM, Stewart DR.

Genome Med. 2018 Dec 24;10(1):99. doi: 10.1186/s13073-018-0607-5.

6.

Author Correction: Telomere length and survival in primary cutaneous melanoma patients.

Rachakonda S, Srinivas N, Mahmoudpour SH, Garcia-Casado Z, Requena C, Traves V, Soriano V, Cardelli M, Pjanova D, Molven A, Gruis N, Nagore E, Kumar R.

Sci Rep. 2018 Dec 14;8(1):17963. doi: 10.1038/s41598-018-36657-w.

7.

Soluble PD-L1 is a potential biomarker of cutaneous melanoma aggressiveness and metastasis in obstructive sleep apnoea patients.

Cubillos-Zapata C, Martínez-García MÁ, Campos-Rodríguez F, Sánchez de la Torre M, Nagore E, Martorell-Calatayud A, Hernández Blasco L, Chiner Vives E, Abad-Capa J, Montserrat JM, Cabriada-Nuño V, Cano-Pumarega I, Corral-Peñafiel J, Diaz-Cambriles T, Mediano O, Somoza-González M, Dalmau-Arias J, Almendros I, Farré R, López-Collazo E, Gozal D, García-Río F; Spanish Sleep Network.

Eur Respir J. 2019 Jan 31;53(2). pii: 1801298. doi: 10.1183/13993003.01298-2018. Print 2019 Feb.

PMID:
30487198
8.

Keeping the Scientific Level of the Journal as a Challenge.

Nagore E.

Actas Dermosifiliogr. 2018 Nov;109(9):763. doi: 10.1016/j.ad.2018.10.001. English, Spanish. No abstract available.

PMID:
30392533
9.

Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk.

Rachakonda S, Kong H, Srinivas N, Garcia-Casado Z, Requena C, Fallah M, Heidenreich B, Planelles D, Traves V, Schadendorf D, Nagore E, Kumar R.

Genes Chromosomes Cancer. 2018 Nov;57(11):564-572. doi: 10.1002/gcc.22669. Epub 2018 Sep 11.

PMID:
30203894
10.

MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Stratigos AJ, Fargnoli MC, De Nicolo A, Peris K, Puig S, Soura E, Menin C, Calista D, Ghiorzo P, Mandala M, Massi D, Rodolfo M, Del Regno L, Stefanaki I, Gogas H, Bataille V, Tucker MA, Whiteman D, Nagore E, Landi MT.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2134-2141. doi: 10.1111/jdv.15208. Epub 2018 Sep 14.

PMID:
30098061
11.

Suitability of melanoma FFPE samples for NGS libraries: time and quality thresholds for downstream molecular tests.

Millán-Esteban D, Reyes-García D, García-Casado Z, Bañuls J, López-Guerrero JA, Requena C, Rodríguez-Hernández A, Traves V, Nagore E.

Biotechniques. 2018 Aug;65(2):79-85. doi: 10.2144/btn-2018-0016.

12.

TERT promoter mutation subtypes and survival in stage I and II melanoma patients.

Andrés-Lencina JJ, Rachakonda S, García-Casado Z, Srinivas N, Skorokhod A, Requena C, Soriano V, Kumar R, Nagore E.

Int J Cancer. 2019 Mar 1;144(5):1027-1036. doi: 10.1002/ijc.31780. Epub 2018 Oct 4.

PMID:
30070694
13.

Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma.

Gu F, Chen TH, Pfeiffer RM, Fargnoli MC, Calista D, Ghiorzo P, Peris K, Puig S, Menin C, De Nicolo A, Rodolfo M, Pellegrini C, Pastorino L, Evangelou E, Zhang T, Hua X, DellaValle CT, Timothy Bishop D, MacGregor S, Iles MI, Law MH, Cust A, Brown KM, Stratigos AJ, Nagore E, Chanock S, Shi J, Consortium MM, Consortium M, Landi MT.

Hum Mol Genet. 2018 Dec 1;27(23):4145-4156. doi: 10.1093/hmg/ddy282.

PMID:
30060076
14.

Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma: A Multicenter Observational Study in 443 Patients.

Martinez-Garcia MA, Campos-Rodriguez F, Nagore E, Martorell A, Rodriguez-Peralto JL, Riveiro-Falkenbach E, Hernandez L, Bañuls J, Arias E, Ortiz P, Cabriada V, Gardeazabal J, Montserrat JM, Carrera C, Corral J, Masa JF, de Terreros JG, Abad J, Boada A, Mediano O, de Eusebio E, Chiner E, Landete P, Mayos M, Fortuño A, Barbé F, Sánchez de la Torre M, Sanchez de la Torre A, Cano I, Gonzalez C, Pérez-Gil A, Gómez-García T, Cullen D, Somoza M, Formigón M, Aizpuru F, Navarro C, Selma-Ferrer MJ, Garcia-Ortega A, de Unamuno B, Almendros I, Farré R, Gozal D; Spanish Sleep Network.

Chest. 2018 Dec;154(6):1348-1358. doi: 10.1016/j.chest.2018.07.015. Epub 2018 Jul 27.

PMID:
30059679
15.

Experience With Vismodegib in the Treatment of Advanced Basal Cell Carcinoma at a Cancer Center.

Bernia E, Llombart B, Serra-Guillén C, Bancalari B, Nagore E, Requena C, Calomarde L, Diago A, Lavernia J, Traves V, Guillén C, Sanmartín O.

Actas Dermosifiliogr. 2018 Nov;109(9):813-820. doi: 10.1016/j.ad.2018.06.003. Epub 2018 Jul 25. English, Spanish.

PMID:
30055751
16.

Telomere length and survival in primary cutaneous melanoma patients.

Rachakonda S, Srinivas N, Mahmoudpour SH, Garcia-Casado Z, Requena C, Traves V, Soriano V, Cardelli M, Pjanova D, Molven A, Gruis N, Nagore E, Kumar R.

Sci Rep. 2018 Jul 19;8(1):10947. doi: 10.1038/s41598-018-29322-9. Erratum in: Sci Rep. 2018 Dec 14;8(1):17963.

17.

A randomized intraindividual comparative study of methyl-5-aminolaevulinate vs. 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp.

Serra-Guillén C, Nagore E, Bancalari E, Kindem S, Sanmartín O, Llombart B, Requena C, Serra-Guillén I, Calomarde L, Diago A, Bernia E, Guillén C.

Br J Dermatol. 2018 Dec;179(6):1410-1411. doi: 10.1111/bjd.17014. Epub 2018 Oct 5. No abstract available.

PMID:
30019337
18.

Intermittent Hypoxia Is Associated With High Hypoxia Inducible Factor-1α but Not High Vascular Endothelial Growth Factor Cell Expression in Tumors of Cutaneous Melanoma Patients.

Almendros I, Martínez-García MÁ, Campos-Rodríguez F, Riveiro-Falkenbach E, Rodríguez-Peralto JL, Nagore E, Martorell-Calatayud A, Hernández Blasco L, Bañuls Roca J, Chiner Vives E, Sánchez-de-la-Torre A, Abad-Capa J, Montserrat JM, Pérez-Gil A, Cabriada-Nuño V, Cano-Pumarega I, Corral-Peñafiel J, Diaz-Cambriles T, Mediano O, Dalmau-Arias J, Farré R, Gozal D; Spanish Sleep Network.

Front Neurol. 2018 Apr 26;9:272. doi: 10.3389/fneur.2018.00272. eCollection 2018.

19.

Lymph Node Dissection in Patients With Melanoma and Sentinel Lymph Node Metastasis: An Updated, Evidence-Based Decision Algorithm.

Moreno-Ramírez D, Boada A, Ferrándiz L, Samaniego E, Carretero G, Nagore E, Redondo P, Ortiz-Romero P, Malvehy J, Botella-Estrada R; miembros del Grupo Español de Dermato-Oncología y Cirugía. Academia Española de Dermatología y Venereología.

Actas Dermosifiliogr. 2018 Jun;109(5):390-398. doi: 10.1016/j.ad.2018.02.008. Epub 2018 Apr 9. English, Spanish.

PMID:
29650221
20.

Dysplastic vs. Common Naevus-associated vs. De novo Melanomas: An Observational Retrospective Study of 1,021 Patients.

Martin-Gorgojo A, Requena C, Garcia-Casado Z, Traves V, Kumar R, Nagore E.

Acta Derm Venereol. 2018 Jun 8;98(6):556-562. doi: 10.2340/00015555-2908.

21.

CDKN2A germline alterations in melanoma patients with personal or familial history of pancreatic cancer.

De Unamuno B, García-Casado Z, Bañuls J, Requena C, Lopez-Guerrero JA, Nagore E.

Melanoma Res. 2018 Jun;28(3):246-249. doi: 10.1097/CMR.0000000000000442.

PMID:
29543703
22.

Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea.

Santamaria-Martos F, Benítez I, Girón C, Barbé F, Martínez-García MA, Hernández L, Montserrat JM, Nagore E, Martorell A, Campos-Rodriguez F, Corral J, Cabriada V, Abad J, Mediano O, Troncoso MF, Cano-Pumarega I, Fortuna Gutierrez AM, Diaz-Cambriles T, Somoza-Gonzalez M, Almendros I, Farre R, Gozal D, Sánchez-de-la-Torre M; Spanish Sleep Network.

Eur Respir J. 2018 Mar 15;51(3). pii: 1701885. doi: 10.1183/13993003.01885-2017. Print 2018 Mar.

PMID:
29519923
23.

Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.

Huerta C, Garcia-Casado Z, Bañuls J, Moragon M, Oliver V, Unamuno B, Requena C, Kumar R, Nagore E.

Acta Derm Venereol. 2018 Apr 27;98(5):512-516. doi: 10.2340/00015555-2898.

24.

Chronology of regional lymph node metastases in cutaneous melanoma: a model based on mitotic rate.

Tejera-Vaquerizo A, Meléndez JJ, Nagore E.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e289-e291. doi: 10.1111/jdv.14824. Epub 2018 Feb 19. No abstract available.

PMID:
29377314
25.

The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.

Armengot-Carbó M, Nagore E, García-Casado Z, Botella-Estrada R.

J Am Acad Dermatol. 2018 May;78(5):920-926.e4. doi: 10.1016/j.jaad.2017.12.064. Epub 2018 Jan 4.

PMID:
29307636
26.

ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression.

Kohli JS, Mir H, Wasif A, Chong H, Akhras V, Kumar R, Nagore E, Bennett DC.

Oncotarget. 2017 Nov 1;8(61):104408-104417. doi: 10.18632/oncotarget.22254. eCollection 2017 Nov 28.

27.

A 12-Day Course of Imiquimod 5% for the Treatment of Actinic Keratosis: Effectiveness and Local Reactions.

Serra-Guillén C, Nagore E, Llombart B, Sanmartín O, Requena C, Calomarde L, Guillén C.

Actas Dermosifiliogr. 2018 Apr;109(3):248-253. doi: 10.1016/j.ad.2017.10.008. Epub 2017 Dec 12. English, Spanish.

PMID:
29246367
28.

Cutaneous melanoma primary site is linked to nevus density.

Martin-Gorgojo A, Llinares M, Virós A, Requena C, Garcia-Casado Z, Traves V, Kumar R, Nagore E.

Oncotarget. 2017 Oct 24;8(58):98876-98886. doi: 10.18632/oncotarget.22016. eCollection 2017 Nov 17. Erratum in: Oncotarget. 2018 Dec 4;9(95):36816.

29.

Clinical assessment of skin phototypes: watch your words!

Trakatelli M, Bylaite-Bucinskiene M, Correia O, Cozzio A, De Vries E, Medenica L, Nagore E, Paoli J, Stratigos AJ, Del Marmol V, Bulliard JL.

Eur J Dermatol. 2017 Dec 1;27(6):615-619. doi: 10.1684/ejd.2017.3129.

30.

Author's reply to: Prognosis of sentinel lymph node biopsy in patients with thick melanoma by a propensity score matching prospective study.

Boada A, Tejera-Vaquerizo A, Ribero S, Puig S, Nagore E, Moreno-Ramírez D, Descalzo-Gallego MA.

Int J Cancer. 2018 Apr 1;142(7):1504. doi: 10.1002/ijc.31162. Epub 2017 Nov 29. No abstract available.

PMID:
29152743
31.

Sentinel lymph node biopsy versus observation in thick melanoma: A multicenter propensity score matching study.

Boada A, Tejera-Vaquerizo A, Ribero S, Puig S, Moreno-Ramírez D, Descalzo-Gallego MA, Fierro MT, Quaglino P, Carrera C, Malvehy J, Vidal-Sicart S, Bennássar A, Rull R, Alos L, Requena C, Bolumar I, Traves V, Pla Á, Fernández-Figueras MT, Ferrándiz C, Pascual I, Manzano JL, Sánchez-Lucas M, Giménez-Xavier P, Ferrandiz L, Nagore E.

Int J Cancer. 2018 Feb 1;142(3):641-648. doi: 10.1002/ijc.31078. Epub 2017 Oct 13.

32.

The intriguing effect of delay time to sentinel lymph node biopsy on survival: a propensity score matching study on a cohort of melanoma patients.

Tejera-Vaquerizo A, Descalzo-Gallego MA, Traves V, Requena C, Bolumar I, Pla A, Nagore E.

Eur J Dermatol. 2017 Oct 1;27(5):487-495. doi: 10.1684/ejd.2017.3065.

PMID:
28944755
33.

A prospective multicenter cohort study of cutaneous melanoma: clinical staging and potential associations with HIF-1α and VEGF expressions.

Martínez-García MÁ, Riveiro-Falkenbach E, Rodríguez-Peralto JL, Nagore E, Martorell-Calatayud A, Campos-Rodríguez F, Farré R, Hernández Blasco L, Bañuls Roca J, Chiner Vives E, Sánchez-de-la-Torre A, Abad Capa J, Montserrat JM, Almendros I, Pérez-Gil A, Cabriada Nuño V, Cano-Pumarega I, Corral Peñafiel J, Diaz Cambriles T, Mediano O, Dalmau Arias J, Gozal D; Spanish Sleep Network.

Melanoma Res. 2017 Dec;27(6):558-564. doi: 10.1097/CMR.0000000000000393.

PMID:
28885396
34.

Clinical, pathological and dermoscopic characteristics of cutaneous lesions in LEOPARD syndrome.

Banuls J, Álvarez-Chinchilla PJ, Lucas A, Poveda I, Encabo-Durán B, Niveiro M, Nagore E, Zaballos P.

J Eur Acad Dermatol Venereol. 2018 Mar;32(3):e100-e101. doi: 10.1111/jdv.14573. Epub 2017 Sep 14. No abstract available.

PMID:
28862807
35.

European Academy of Dermatology and Venereology (EADV) membership is worthwhile for Spanish dermatologists.

Nagore E, Puig L.

Actas Dermosifiliogr. 2017 Sep;108(7):605. doi: 10.1016/j.ad.2017.07.007. English, Spanish. No abstract available.

PMID:
28859753
36.

Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.

Taylor NJ, Mitra N, Goldstein AM, Tucker MA, Avril MF, Azizi E, Bergman W, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Grazziotin TC, Hansson J, Harland M, Hayward NK, Hocevar M, Höiom V, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer JM, Perić B, Pjanova D, Pritchard A, Puig S, van der Stoep N, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA; GenoMEL Study Group.

J Invest Dermatol. 2017 Dec;137(12):2606-2612. doi: 10.1016/j.jid.2017.07.829. Epub 2017 Aug 19.

37.

Melanoma Arising in a Melanocytic Nevus.

Martín-Gorgojo A, Nagore E.

Actas Dermosifiliogr. 2018 Mar;109(2):123-132. doi: 10.1016/j.ad.2017.06.009. Epub 2017 Aug 14. Review. English, Spanish.

PMID:
28818288
38.

Use of Lymph Node Ultrasound Prior to Sentinel Lymph Node Biopsy in 384 Patients with Melanoma: A Cost-Effectiveness Analysis.

Olmedo D, Brotons-Seguí M, Del Toro C, González M, Requena C, Traves V, Pla A, Bolumar I, Moreno-Ramírez D, Nagore E.

Actas Dermosifiliogr. 2017 Dec;108(10):931-938. doi: 10.1016/j.ad.2017.06.002. Epub 2017 Aug 8. English, Spanish.

PMID:
28801012
39.

Is mitotic rate still useful in the management of patients with thin melanoma?

Tejera-Vaquerizo A, Pérez-Cabello G, Marínez-Leborans L, Gallego E, Oliver-Martínez V, Martín-Cuevas P, Arias-Santiago S, Aneiros-Fernández J, Herrera-Acosta E, Traves V, Herrera-Ceballos E, Nagore E.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2025-2029. doi: 10.1111/jdv.14485. Epub 2017 Aug 22.

PMID:
28750139
40.

Skin Cancer and the Dermatologist: Reflections on the Position Taken by the Spanish Society of Medical Oncology (SEOM).

Moreno-Ramírez D, Nagore E, Botella-Estrada R, Carretero G, Puig S, Redondo P, Rodrígurez-Prieto MA, Samaniego E, Sanmartín O, Malvehy J.

Actas Dermosifiliogr. 2017 Oct;108(8):704-707. doi: 10.1016/j.ad.2017.06.003. Epub 2017 Jul 10. English, Spanish. No abstract available.

PMID:
28705520
41.

Commentaries: More Than Just a New Section in Actas.

Gilaberte Y, Moreno D, Arias-Santiago S, Nagore E.

Actas Dermosifiliogr. 2017 May;108(4):281. doi: 10.1016/j.ad.2017.03.006. English, Spanish. No abstract available.

PMID:
28457519
42.

Subcutaneous dermatofibrosarcoma protuberans, a rare subtype with predilection for the head: A retrospective series of 18 cases.

Llombart B, Serra-Guillén C, Rubio L, Nagore E, Requena C, Traves V, Calomarde L, Bancalari B, López-Guerrero JA, Guillen-Barona C, Sanmartín O.

J Am Acad Dermatol. 2017 Sep;77(3):503-511.e1. doi: 10.1016/j.jaad.2017.02.046. Epub 2017 Apr 15.

PMID:
28420485
43.

Genetic alterations in seborrheic keratoses.

Heidenreich B, Denisova E, Rachakonda S, Sanmartin O, Dereani T, Hosen I, Nagore E, Kumar R.

Oncotarget. 2017 May 30;8(22):36639-36649. doi: 10.18632/oncotarget.16698.

44.

Desmoplastic melanoma may mimic a cutaneous peripheral nerve sheath tumor: Report of 3 challenging cases.

Machado I, Llombart B, Cruz J, Traves V, Requena C, Nagore E, Parafioriti A, Monteagudo C, Llombart-Bosch A.

J Cutan Pathol. 2017 Apr 12. doi: 10.1111/cup.12949. [Epub ahead of print]

PMID:
28403573
45.

TERT promoter mutations associate with MC1R variants in melanoma patients.

Nagore E, Reyes-Garcia D, Heidenreich B, Garcia-Casado Z, Requena C, Kumar R.

Pigment Cell Melanoma Res. 2017 Mar;30(2):273-275. doi: 10.1111/pcmr.12567. Epub 2017 Mar 6. No abstract available.

PMID:
27930874
46.

TERT promoter mutations are not always associated with poor prognosis in atypical spitzoid tumors.

Requena C, Heidenreich B, Kumar R, Nagore E.

Pigment Cell Melanoma Res. 2017 Mar;30(2):265-268. doi: 10.1111/pcmr.12565. Epub 2017 Mar 6. No abstract available.

PMID:
27930864
47.

Sunbed use among Portuguese beach goers: a crave group while waiting sunbeds to be abolished.

Duarte AF, Maia Silva JN, Costa Pereira A, Nagore E, Picoto A, Correia O.

J Eur Acad Dermatol Venereol. 2017 Jun;31(6):e294-e295. doi: 10.1111/jdv.14070. Epub 2016 Dec 27. No abstract available.

PMID:
27896872
48.

25-Hydroxyvitamin D in Patients With Melanoma and Factors Associated With Inadequate Levels.

Hernández-Ostiz S, Pérez-Ramada MD, Ortiz B, Requena C, Ribas G, Aznar E, Nagore E.

Actas Dermosifiliogr. 2016 Nov;107(9):758-764. doi: 10.1016/j.ad.2016.06.002. Epub 2016 Jul 11. English, Spanish.

PMID:
27418183
49.

Effect of time to sentinel lymph node biopsy on cutaneous melanoma survival: a matter of discussion.

Tejera-Vaquerizo A, Nagore E.

Am J Surg. 2017 Jan;213(1):204-205. doi: 10.1016/j.amjsurg.2016.06.014. Epub 2016 Jul 21. No abstract available.

PMID:
27528584
50.

Behaviour towards sun exposure, skin self-examination and skin cancer knowledge of educators, health professionals and the general population - cross-sectional study.

Duarte AF, Correia B, Picoto A, Costa Pereira A, Nagore E, Correia O.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e132-e135. doi: 10.1111/jdv.13878. Epub 2016 Aug 13. No abstract available.

PMID:
27520118

Supplemental Content

Loading ...
Support Center